ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Deep Learning-Based Prediction of Future Extrahepatic Metastasis and Macrovascular Invasion in Hepatocellular Carcinoma

Fu, Sirui; Pan, Meiqing; Zhang, Jie; Zhang, Hui; Tang, Zhenchao; Li, Yong; Mu, Wei; Huang, Jianwen; Dong, Di; Duan, Chongyang; Li, Xiaoqun; Wang, Shuo; Chen, Xudong; He, Xiaofeng; Yan, Jianfeng; Lu, Ligong*; Tian, Jie*北京航空航天大学; 南方医科大学; 中国科学院研究生院; 中国科学院
Journal of Hepatocellular Carcinoma2021DOI: 10.2147/JHC.S319639
5被引6阅读
引用收藏
分享

摘要

Purpose: For timely treatment of extrahepatic metastasis and macrovascular invasion (aggressive progressive disease [PD]) in hepatocellular carcinoma, models aimed at stratifying the risks of subsequent aggressive PD should be constructed. @@@ Patients and Methods: After dividing 332 patients from five hospitals into training (n = 236) and validation (n = 96) datasets, non-invasive models, including clinical/semantic factors (Model(CS)), deep learning radiomics (Model(D)), and both (Model(CSD)), were constructed to stratify patients according to the risk of aggressive PD. We examined the discrimination and calibration; similarly, we plotted a decision curve and devised a nomogram. Furthermore, we performed analyses of subgroups who received different treatments or those in different disease stages and compared time to aggressive PD and overall survival in the high- and low-risk subgroups. @@@ Results: Among the constructed models, Model(CSD), combining clinical/semantic factors and deep learning radiomics, outperformed Model(CS) and Model(D) (areas under the curve [AUCs] for the training dataset: 0.741, 0.815, and 0.856; validation dataset: 0.780, 0.836, and 0.862), with statistical difference per the net reclassification improvement, the integrated discrimination improvement, and/or the DeLong test in both datasets. Besides, Model(CSD) had the best calibration and decision curves. The performance of Model(CSD) was not affected by treatment types (AUC: resection = 0.839; transarterial chemoembolization = 0.895; p = 0.183) or disease stages (AUC: BCLC [Barcelona Clinic Liver Cancer] stage 0 and A = 0.827; BCLC stage AB &B = 0.861; p = 0.537). Moreover, the high-risk group had a significantly shorter median time to aggressive PD than the low-risk group (training dataset hazard ratio [HR] = 0.108, p < 0.001; validation dataset HR = 0.058, p < 0.001) and poorer overall survival (training dataset HR = 0.357, p < 0.001; validation dataset HR = 0.204, p < 0.001). @@@ Conclusion: Our deep learning-based model successfully stratified the risks of aggressive PD. In the high-risk population, current guideline indicates that first-line treatments are insufficient to prevent extrahepatic metastasis and macrovascular invasion and ensure survival benefits, so more therapies may be explored for these patients.

学科与关键词

关键词
aggressive disease progressiondeep learning radiomicsclinical factorshigh-riskrisk prediction
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Hepatocellular Carcinoma
发表日期
2021
卷期
第 8 卷
页码
1065-1076
DOI
10.2147/JHC.S319639
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Key R&D Program of China [2017YFA0205200, 2017YFC1308700]; National Natural Science Foundation of China [62027901, 82001914, 81871511]; Project of High-Level Talents Team Introduction in Zhuhai City [Zhuhai HLHPTP201703]; Nurture Programme of Zhuhai People's Hospital [2019-PY-07, 2020XSYC-09]

作者

  • F

    Fu, Sirui (第一作者)

    zhuhai peoples hosp · beihang univ

  • P

    Pan, Meiqing

    beihang univ · cas · chinese acad sci

查看全部 17 位作者收起作者
  • Z

    Zhang, Jie

    zhuhai peoples hosp

  • Z

    Zhang, Hui

    beihang univ · cas · chinese acad sci

  • T

    Tang, Zhenchao

    beihang univ · cas · chinese acad sci

  • L

    Li, Yong

    zhuhai peoples hosp

  • M

    Mu, Wei

    beihang univ · cas · chinese acad sci

  • H

    Huang, Jianwen

    zhuhai peoples hosp

  • D

    Dong, Di

    cas · chinese acad sci

  • D

    Duan, Chongyang

    southern med univ

  • L

    Li, Xiaoqun

    zhongshan city peoples hosp

  • W

    Wang, Shuo

    beihang univ · cas · chinese acad sci

  • C

    Chen, Xudong

  • H

    He, Xiaofeng

    southern med univ

  • Y

    Yan, Jianfeng

  • L

    Lu, Ligong (通讯)

    zhuhai peoples hosp

  • T

    Tian, Jie (通讯)

    beihang univ · cas · chinese acad sci · univ chinese acad sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417